Targeted nanomedicines have appeared as an innovative and promising modality for targeted cancer therapy, including hematological malignancies and solid tumors. However, the human tumors are very complicated and can vary to a great extent in receptor density, heterogenicity, and accessibility from different tumor types and subtypes, volumes, and stages. Hence, we have to design vary targeted nanomedicines for vary patients, i.e. precision therapy and personalized nanomedicine. This thesis starts with a preface, including general introduction of targeted nanomedicines for cancer therapy, and aim/outline of the thesis, which briefly describes the background, what we want to do and what have been achieved.
|Qualification||Doctor of Philosophy|
|Award date||2 Jul 2021|
|Place of Publication||Enschede|
|Publication status||Published - 2 Jul 2021|